1. Home
  2. DK vs NNNN Comparison

DK vs NNNN Comparison

Compare DK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$45.18

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
NNNN
Founded
2001
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
DK
NNNN
Price
$45.18
$25.67
Analyst Decision
Hold
Analyst Count
17
0
Target Price
$36.94
N/A
AVG Volume (30 Days)
1.3M
20.3K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
2.27%
N/A
EPS Growth
95.67
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.50
N/A
Revenue Next Year
$0.58
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$11.07
$5.91
52 Week High
$48.32
$55.65

Technical Indicators

Market Signals
Indicator
DK
NNNN
Relative Strength Index (RSI) 58.55 56.03
Support Level $36.00 $19.53
Resistance Level $48.32 $30.70
Average True Range (ATR) 2.51 2.11
MACD -0.31 0.52
Stochastic Oscillator 54.19 71.53

Price Performance

Historical Comparison
DK
NNNN

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: